The effect of curcumin on the treatment of human papillomavirus infectio
Phase 3
Recruiting
- Conditions
- Cervical human papilloma virus infection.
- Registration Number
- IRCT20220629055314N1
- Lead Sponsor
- Arak University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 90
Inclusion Criteria
Women with high-risk Pap smear and HPV results
Age 30 to 65 years
Exclusion Criteria
Known immune deficiency or autoimmune disease
HIV positive patients
Long-term use of corticosteroids or immunosuppressants
smoking
Pregnancy
Infection with CIN2 or CIN3 in cervical biopsy
Use of anticoagulants such as heparin, aspirin, clopidogrel, dipyridamole, warfarin and ticlopidine
History of allergies to turmeric or other drugs, foods and dyes
Gallbladder stones or bile duct obstruction and diseases related to gastric acidosis or active gastrointestinal ulcers
Candida, trichomoniasis, and other infections of the cervix or vaginitis
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Clearance of human papillomavirus infection from the cervix. Timepoint: Before the intervention and 6 months later. Method of measurement: Detection and Typing of Human Papilloma Virus by PCR.;Diagnostic quality of cervical smear. Timepoint: Before the intervention and 6 months later. Method of measurement: Pap smear sampling from the cervix.
- Secondary Outcome Measures
Name Time Method